Literature DB >> 27563081

Europe's new hepatitis problem.

Kai Kupferschmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27563081     DOI： 10.1126/science.353.6302.862

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  8 in total

1.  Infectious Screening of Blood Components: Is There Still a Need for Further Inventions?

Authors:  Jens Dreier; Tanja Vollmer
Journal:  Transfus Med Hemother       Date:  2019-03-14       Impact factor: 3.747

2.  Hepatitis E virus seroprevalence and determinants in various study populations in the Netherlands.

Authors:  C J Alberts; M F Schim van der Loeff; S Sadik; F R Zuure; E J A J Beune; M Prins; M B Snijder; S M Bruisten
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

3.  Viability RT-qPCR to Distinguish Between HEV and HAV With Intact and Altered Capsids.

Authors:  Walter Randazzo; Andrea Vasquez-García; Rosa Aznar; Gloria Sánchez
Journal:  Front Microbiol       Date:  2018-08-24       Impact factor: 5.640

4.  Palmitoylation mediates membrane association of hepatitis E virus ORF3 protein and is required for infectious particle secretion.

Authors:  Jérôme Gouttenoire; Angela Pollán; Laurence Abrami; Noémie Oechslin; Johann Mauron; Maxime Matter; Joël Oppliger; Dagmara Szkolnicka; Viet Loan Dao Thi; F Gisou van der Goot; Darius Moradpour
Journal:  PLoS Pathog       Date:  2018-12-10       Impact factor: 6.823

5.  Hepatitis E should be considered a neglected tropical disease.

Authors:  Andrew S Azman; Iza Ciglenecki; Joseph F Wamala; Julia Lynch; Rakesh Aggarwal; Mahmudur Rahman; Sid Wong; Micaela Serafini; Ali M Moussa; Harry R Dalton; Ananta Shrestha; Rajendra Pant; Raquel Peck; Emily S Gurley
Journal:  PLoS Negl Trop Dis       Date:  2019-07-25

6.  Autochthonous hepatitis E: a common and fatal but neglected emerging disease in France.

Authors:  P Colson; D Raoult
Journal:  Clin Microbiol Infect       Date:  2017-06-29       Impact factor: 8.067

7.  Interleukin-22 drives a metabolic adaptive reprogramming to maintain mitochondrial fitness and treat liver injury.

Authors:  Wei Chen; Wenjing Zai; Jiajun Fan; Xuyao Zhang; Xian Zeng; Jingyun Luan; Yichen Wang; Yilan Shen; Ziyu Wang; Shixuan Dai; Si Fang; Zhen Zhao; Dianwen Ju
Journal:  Theranostics       Date:  2020-04-27       Impact factor: 11.556

Review 8.  Hepatitis E Virus Infection: Neurological Manifestations and Pathophysiology.

Authors:  Sébastien Lhomme; Florence Abravanel; Pascal Cintas; Jacques Izopet
Journal:  Pathogens       Date:  2021-12-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.